Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Donald W Nibbelink is active.

Publication


Featured researches published by Donald W Nibbelink.


Journal of Clinical Psychology | 1993

Factor structure and scoring of the SKT test battery

Yong S. Kim; Donald W Nibbelink; John E. Overall

The SKT (Syndrom Kurztest) has been used in the assessment of treatment responses in numerous clinical trials for treatment of dementia in German-speaking Europe. Data from 265 patients with mild to moderate Alzheimers disease in a study conducted in the U.S. were analyzed to evaluate factor structure, common and specific subtest content, reliability, and concurrent validity. Results confirm the presence of two primary factors of memory and attention. Test-retest reliability of the factor scores was estimated to be .75 and .93. Test-retest reliability of the composite SKT total score was .90. The correlations between the SKT memory and attention factor scores and the MMSE and ADAS measurements of dementia also support validity with regard to the broader construct of cognitive dysfunction.


European Neurology | 1997

Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's Disease : A multicenter 5-year study

Gilbert A. Block; Charles Liss; Scott A. Reines; Joseph D. Irr; Donald W Nibbelink; Johan A. Aarli; Miquel Aguilar; Suzanne P. Ahrens; A. Bakheit; Barry Baumel; John M. Bertoni; Rudy Capildeo; Alexandre Castro-Caldas; Luis Deza; Ivan Donaldson; Georges Franck; Jose Fusillo; Serge Gauthier; Oscar Gershanik; Ann Katherine Granerus; Robert A. Hauser; Keven Hennessey; J. Thomas Hutton; Ronald Joffe; William C. Koller; Peter A. LeWitt; Bruno Mamoli; Bala Manyam; Margery H. Mark; Kenneth Nakano


European Neurology | 1997

Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's disease. A multicenter 5-year study. The CR First Study Group

Gilbert A. Block; Charles Liss; Scott A. Reines; Joseph D. Irr; Donald W Nibbelink


Archive | 1991

Deprenyl/L-dopa/carbidopa pharmaceutical composition

Albert Walter Brzeczko; Donald W Nibbelink; Joseph A. Mollica


Archive | 1995

Præparat til reguleret frigivelse af carbidopa og levodopa

Robert E. Dempski; Edward C Scholtz; Donald W Nibbelink; Scott A. Reines


Archive | 1991

Deprenyl, L-Dopa und Carbidopa enthaltende pharmazeutische Zusammensetzung

Albert Walter Brzeczko; Donald W Nibbelink; Joseph A. Mollica


Archive | 1991

Deprenyl/l-dopa/carbidopa-containing pharmaceutical composition

Albert Walter Brzeczko; Joseph A. Mollica; Donald W Nibbelink; アルバート・ウオールター・ブルゼチユコ; ジヨゼフ・エイ・モリカ; ドナルド・ウイルフリド・ニベリンク


Archive | 1991

デプレニル/l−ドーパ/カルビドーパ含有の医薬組成物

Albert Walter Brzeczko; Joseph A. Mollica; Donald W Nibbelink; アルバート・ウオールター・ブルゼチユコ; ジヨゼフ・エイ・モリカ; ドナルド・ウイルフリド・ニベリンク


Archive | 1991

Composition pharmaceutique contenant du déprenyl, du L-dopa et du carbidopa

Albert Walter Brzeczko; Donald W Nibbelink; Joseph A. Mollica


Archive | 1991

Composition pharmaceutique a base de deprenyl/l-dopa/carbidopa

Albert Walter Brzeczko; Donald W Nibbelink; Joseph A. Mollica

Collaboration


Dive into the Donald W Nibbelink's collaboration.

Researchain Logo
Decentralizing Knowledge